Related Experiment Video
Updated: May 6, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
Mucopolysaccharidosis Type IIIB With Pancytopenia: A Case Report and Hematological Correlations in Mice
Éliane Beauregard-Lacroix1, Patricia Dubot2, Alexey V Pshezhetsky2
1Medical Genetics Division, Department of Pediatrics, CHU Sainte-Justine, Montreal, QC, Canada.
Abstract:
Mucopolysaccharidosis type IIIB (MPS IIIB), also called Sanfilippo syndrome B, is a lysosomal storage disease caused by abnormal degradation of heparan sulfate. It is characterized by progressive neurological deterioration with developmental regression and behavioral abnormalities. Additional clinical manifestations can include musculoskeletal anomalies, hearing loss, respiratory tract anomalies, and cardiovascular disease. Here, we report a second individual with MPS IIIB and chronic pancytopenia. To support our hypothesis of a pathophysiological relationship between these clinical findings, we performed hematological studies in MPS IIIB Naglu-/- mice, which revealed a microcytic anemia as well as a decreased monocyte count, without thrombocytopenia. Hematological findings are thought to be secondary to MPS IIIB even though the exact pathophysiological mechanism remains to be determined. Although it likely represents an uncommon clinical feature, we suggest that complete blood count should be considered as part of the clinical surveillance for individuals with MPS IIIB.
Insights
Mucopolysaccharidosis type IIIB (MPS IIIB), or Sanfilippo syndrome B, is a rare genetic disorder. This study suggests monitoring complete blood counts in MPS IIIB patients due to observed hematological abnormalities.
Area of Science:
- Biochemistry
- Genetics
- Hematology
Background:
- Mucopolysaccharidosis type IIIB (MPS IIIB), or Sanfilippo syndrome B, is a lysosomal storage disease resulting from impaired heparan sulfate degradation.
- MPS IIIB typically presents with severe neurological decline, developmental regression, and behavioral issues, alongside other systemic complications.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Hypoglycemia

